Michael Hearne

Michael Hearne

Director Financiero/CFO en ODONATE, INC. .

Fortuna: 2 M $ al 31/05/2026

63 años
Health Technology
Commercial Services
Consumer Services

Perfil

Michael S.
Hearne
is currently Chief Financial Officer at Kezar Life Sciences, Inc. since 2026, Chief Financial Officer at Aurinia Pharmaceuticals, Inc. since 2026, and Chief Financial Officer at Odonate, Inc. since 2018.
Former roles include Managing Director & Principal at Carson Private Capital, Inc., Partner at Rothstein, Kass & Co. LLC from 2000 to 2008, Partner at Weaver & Tidwell LLP from 2014 to 2015, and Chief Financial & Accounting Officer at La Jolla Pharmaceutical Co. Education includes undergraduate and graduate degrees from Brigham Young University and an undergraduate degree from Texas A&M University conferred in 1989.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
18/05/2026 116.144 ( 0,09 % ) 2 M $ 31/05/2026

Cargos activos de Michael Hearne

EmpresasCargoInicio
ODONATE, INC. Director Financiero/CFO 19/11/2018
AURINIA PHARMACEUTICALS INC. Director Financiero/CFO 23/03/2026
KEZAR LIFE SCIENCES, INC. Director Financiero/CFO 11/05/2026

Antiguos cargos conocidos de Michael Hearne.

EmpresasCargoFin
Corporate Officer/Principal 01/01/2015
Corporate Officer/Principal 01/01/2008
LA JOLLA PHARMACEUTICAL COMPANY Director Financiero/CFO -
Inversor de Capital Privado -
Ver el detalle de la experiencia de Michael Hearne.

Formación de Michael Hearne.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

78

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Health Technology

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology